ABRE continuously evaluates emerging risk conditions across multiple signal domains, including biological, environmental, industrial, informational, and supply-chain systems, to identify early indicators and convergence patterns that historically precede large-scale outbreaks, force health impacts, and systemic disruption. By focusing on early signal detection rather than relying on single data points or reactive alerts, the system emphasizes pattern alignment across disparate signals. This approach helps leaders recognize when conditions are forming that warrant attention, well before traditional thresholds are crossed, ultimately enhancing biological supply chain resilience. The objective is not surveillance, but rather the early recognition of risk trajectories that may otherwise go unnoticed until consequences are already unfolding, aiding in effective threat prediction.
ABRE applies forward-looking analysis to estimate plausible threat evolution pathways once early signal detection indicators begin to align. By forecasting how biological and systemic threats may develop over time, the system enhances biological supply chain resilience and enables leaders to understand: What is likely to happen next, how quickly conditions may escalate, and where intervention could have the greatest effect. This threat prediction capability supports proactive planning and reduces reliance on reactive decision-making once options have narrowed.

ABRE is designed to simulate second- and third-order effects of emerging threats across domains critical to military operations, such as biological supply chain resilience, early signal detection, and threat prediction. Key areas of focus include: force readiness and availability, medical capacity and pharmaceutical supply continuity, logistics and sustainment systems, and mission execution and operational tempo. These simulations enable decision-makers to explore "what-if" scenarios, assess tradeoffs, and understand downstream consequences before committing resources or authorities.

ABRE enhances biological supply chain resilience by providing early signal detection and predictive analysis for biological supply chains that are crucial to national security, including food systems, livestock production, and the manufacturing of critical pharmaceutical active ingredients (APIs) and key starting materials (KSMs).
Disruptions in the biological supply chain can lead to workforce shortages, manufacturing delays, medical shortages, and increased readiness risk. ABRE™ is designed to assist leaders in threat prediction by enabling them to anticipate these cascading effects early, allowing for preemptive mitigation before localized events escalate into strategic disruptions.

ABRE is designed around a single principle: awareness without action is insufficient. By integrating early signal detection, threat prediction, simulation, and decision playbooks into a unified system, ABRE enhances biological supply chain resilience and supports a shift from reactive response to predictive readiness. This enables leadership to act earlier, with greater confidence, and with a clearer understanding of consequences.

Copyright © 2026 USAPI Pharma, PBC. All Rights Reserved. USAPI Pharma is a Public Benefit Corporation focused on building national security readiness and pharmaceutical resilience. Information on this site is for general informational purposes only and does not imply or constitute any partnership, approval, or endorsement by the U.S. Government or its agencies. Unauthorized reproduction or distribution is prohibited.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.